Access the full text.
Sign up today, get DeepDyve free for 14 days.
This study suggests that management of modifiable risk factors (e.g., control of diabetes) should be undertaken in HIV/HCV-coinfected patients on ART
A. Butt, P. Yan, V. Re, D. Rimland, M. Goetz, D. Leaf, M. Freiberg, M. Klein, A. Justice, K. Sherman (2015)Liver fibrosis progression in hepatitis C virus infection after seroconversion.
JAMA internal medicine, 175 2
This review updates the knowledge on the distinct extra-hepatic manifestations of chronic HCV infection, with a special focus on immune and rheumatologic conditions
J. Brenchley, D. Price, T. Schacker, Tedi Asher, G. Silvestri, Srinivas Rao, Zachary Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, B. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, Jeffrey Martin, F. Hecht, L. Picker, M. Lederman, S. Deeks, D. Douek (2006)Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Nature Medicine, 12
M. Freiberg, C. Chang, L. Kuller, M. Skanderson, Elliott Lowy, K. Kraemer, A. Butt, M. Goetz, D. Leaf, K. Oursler, D. Rimland, M. Barradas, Sheldon Brown, C. Gibert, K. McGinnis, K. Crothers, J. Sico, H. Crane, A. Warner, S. Gottlieb, J. Gottdiener, R. Tracy, M. Budoff, C. Watson, K. Armah, D. Doebler, K. Bryant, A. Justice (2013)HIV infection and the risk of acute myocardial infarction.
JAMA internal medicine, 173 8
L. Henry, Z. Younossi (2014)Hepatitis. Chronic HCV infection, diabetes and liver-related outcomes.
Nature reviews. Gastroenterology & hepatology, 11 9
J. Gillis, M. Smieja, A. Cescon, S. Rourke, A. Burchell, C. Cooper, J. Raboud (2014)Risk of Cardiovascular Disease Associated with HCV and HBV Coinfection among Antiretroviral-Treated HIV-Infected Individuals
Antiviral Therapy, 19
D. Saadoun, D. Landau, L. Calabrese, P. Cacoub (2007)Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.
Rheumatology, 46 8
Torsten Roed, U. Kristoffersen, A. Knudsen, N. Wiinberg, A. Lebech, T. Almdal, R. Thomsen, A. Kjær, N. Weis (2014)Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study
Vascular Health and Risk Management, 10
L. Morton, S. Slager, J. Cerhan, Sophia Wang, C. Vajdic, C. Skibola, P. Bracci, S. Sanjosé, K. Smedby, B. Chiu, Yawei Zhang, S. Mbulaiteye, A. Monnereau, J. Turner, J. Clavel, H. Adami, E. Chang, B. Glimelius, H. Hjalgrim, M. Melbye, P. Crosignani, S. Lollo, L. Miligi, O. Nanni, V. Ramazzotti, S. Rodella, A. Costantini, E. Stagnaro, R. Tumino, C. Vindigni, P. Vineis, N. Becker, Y. Benavente, P. Boffetta, P. Brennan, P. Cocco, L. Foretova, M. Maynadie, A. Nieters, A. Staines, J. Colt, W. Cozen, S. Davis, A. Roos, P. Hartge, N. Rothman, R. Severson, E. Holly, T. Call, A. Feldman, T. Habermann, M. Liebow, A. Blair, K. Cantor, E. Kane, T. Lightfoot, E. Roman, Alex Smith, A. Brooks-Wilson, J. Connors, R. Gascoyne, J. Spinelli, B. Armstrong, A. Kricker, T. Holford, Q. Lan, T. Zheng, L. Orsi, L. Maso, S. Franceschi, C. Vecchia, E. Negri, D. Serraino, L. Bernstein, Alexandra Levine, J. Friedberg, J. Kelly, S. Berndt, B. Birmann, C. Clarke, C. Flowers, J. Foran, M. Kadin, O. Paltiel, D. Weisenburger, M. Linet, J. Sampson (2014)Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Journal of the National Cancer Institute. Monographs, 2014 48
S. Satapathy, Y. Kim, A. Kataria, Arash Shifteh, R. Bhansali, M. Cerulli, D. Bernstein (2013)Higher Prevalence and More Severe Coronary Artery Disease in Hepatitis C Virus-infected Patients: A Case Control Study.
Journal of clinical and experimental hepatology, 3 3
R. Zampino, A. Marrone, L. Restivo, B. Guerrera, A. Sellitto, L. Rinaldi, C. Romano, L. Adinolfi (2013)Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
World journal of hepatology, 5 10
Scott Cornella, J. Stine, V. Kelly, S. Caldwell, Neeral Shah (2015)Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series
Postgraduate Medicine, 127
T. Pawłowski, M. Radkowski, K. Małyszczak, M. Inglot, M. Zalewska, J. Jabłońska, T. Laskus (2014)Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 60 2
G. Caviglia, C. Sciacca, M. Abate, A. Olivero, C. Rosso, G. Touscoz, A. Ciancio, M. Rizzetto, A. Smedile (2015)Chronic hepatitis C virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B‐cell non‐Hodgkin lymphoma
Journal of Gastroenterology and Hepatology, 30
Ching-Sheng Hsu, J. Kao, Y. Chao, Heng-Dao Lin, Y.‐C. Fan, C.‐J. Huang, P. Tsai, P. Tsai (2013)Interferon‐based therapy reduces risk of stroke in chronic hepatitis C patients: a population‐based cohort study in Taiwan
Alimentary Pharmacology & Therapeutics, 38
L. Backus, D. Boothroyd, B. Phillips, P. Belperio, J. Halloran, L. Mole (2011)A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 9 6
S. Villano, D. Vlahov, K. Nelson, S. Cohn, David Thomas (1999)Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection
Y. Arase, M. Kobayashi, Y. Kawamura, F. Suzuki, Yoshiyuki Suzuki, N. Akuta, M. Kobayashi, H. Sezaki, Satoshi Saito, T. Hosaka, K. Ikeda, H. Kumada, Tetsuro Kobayashi (2014)Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C
Journal of Medical Virology, 86
N. Ishizaka, Y. Ishizaka, Minoru Yamkado (2014)Atherosclerosis As a Possible Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection
Clinical Medicine Insights. Cardiology, 8
This is a free website updated periodically that records information for the management of chronic hepatitis C and propose the best therapeutic interventions
S. Maruyama, M. Koda, N. Oyake, H. Sato, Y. Fujii, Y. Horie, Y. Murawaki (2013)Myocardial injury in patients with chronic hepatitis C infection.
Journal of hepatology, 58 1
Yi-Wen Huang, Sien‐Sing Yang, Szu-Chieh Fu, Ting-Chuan Wang, Cheng-Kai Hsu, Ding‐Shinn Chen, Jui-Ting Hu, J. Kao (2014)Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new‐onset diabetes: A nationwide cohort study
Jennifer McCombe, P. Vivithanaporn, P. Vivithanaporn, M. Gill, Christopher Power, Christopher Power (2013)Predictors of symptomatic HIV‐associated neurocognitive disorders in universal health care
HIV Medicine, 14
Yao-Chun Hsu, H. Ho, Yen-Tsung Huang, Hsi-Hao Wang, Ming-Shiang Wu, Jaw-Town Lin, Chun-Ying Wu (2014)Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection
Saurabh Gupta, J. Iudicello, C. Shi, S. Letendre, A. Knight, Jian-hua Li, P. Riggs, D. Franklin, N. Duarte, Hua Jin, J. Atkinson, Xin Yu, Zunyou Wu, I. Grant, R. Heaton (2014)Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.
Drug and alcohol dependence, 137
A. Abraham, K. Althoff, Yuezhou Jing, M. Estrella, M. Kitahata, C. Wester, R. Bosch, Heidi Crane, J. Eron, M. Gill, M. Horberg, A. Justice, M. Klein, Á. Mayor, Richard Moore, F. Palella, C. Parikh, M. Silverberg, E. Golub, L. Jacobson, S. Napravnik, G. Lucas, Gregory Kirk, Constance Benson, Ann Collier, Stephen Boswell, C. Grasso, Kenneth Mayer, Robert Hogg, Richard Harrigan, J. Montaner, A. Cescon, J. Brooks, K. Buchacz, K. Gebo, B. Rodriguez, Jennifer Thorne, J. Goedert, M. Klein, Sean Rourke, A. Burchell, Anita Rachlis, R. Hunter-Mellado, S. Deeks, Jeffrey Martin, M. Saag, M. Mugavero, J. Willig, J. Eron, Heidi Crane, R. Dubrow, David Fiellin, T. Sterling, David Haas, Sally Bebawy, M. Turner, S. Gange, K. Anastos, R. Mckaig, Aimee Freeman, Carol Lent, S. Rompaey, Eric Webster, Liz Morton, Brenda Simon, Bryan Lau, Jinbing Zhang, Jerry Jing, Shari Modur, David Hanna, Peter Rebeiro, Cherise Wong, A. Mendes (2015)End-stage renal disease among HIV-infected adults in North America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60 6
J. Margolick, L. Jacobson, G. Schwartz, A. Abraham, A. Darilay, L. Kingsley, M. Witt, F. Palella (2014)Factors Affecting Glomerular Filtration Rate, as Measured by Iohexol Disappearance, in Men with or at Risk for HIV Infection
PLoS ONE, 9
P. Cacoub, L. Gragnani, C. Comarmond, A. Zignego (2014)Extrahepatic manifestations of chronic hepatitis C virus infection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 46 Suppl 5
I. Gentile, A. Buonomo, E. Zappulo, G. Borgia (2014)Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
Expert Review of Anti-infective Therapy, 12
J. Smith-Palmer, K. Cerri, W. Valentine (2015)Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits
BMC Infectious Diseases, 15
A. Azmi, S. Tan, R. Mohamed (2015)Hepatitis C and kidney disease: An overview and approach to management.
World journal of hepatology, 7 1
F. Negro (2014)Hepatitis C in 2013: HCV causes systemic disorders that can be cured
Nature Reviews Gastroenterology &Hepatology, 11
E. Gower, C. Estes, S. Blach, K. Razavi-Shearer, H. Razavi (2014)Global epidemiology and genotype distribution of the hepatitis C virus infection.
Journal of hepatology, 61 1 Suppl
Madeleine Durand, O. Sheehy, J. Baril, J. LeLorier, C. Tremblay (2013)Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 22 7
J. Berenguer, J. Álvarez-Pellicer, A. Carrero, M. Wichmann, J. López-aldeguer, J. Mallolas, M. Galindo, E. Eynde, M. Téllez, C. Quereda, C. Tural, J. Sanz, C. Barros, I. Santos, F. Pulido, J. Guardiola, E. Ortega, R. Rubio, J. Jusdado, M. Montes, G. Gaspar, E. Barquilla, J. Bellón, J. González-García (2013)Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Journal of hepatology, 58 6
C. Besson, D. Canioni, É. Lepage, S. Pol, P. Morel, P. Lederlin, A. Hoof, H. Tilly, P. Gaulard, B. Coiffier, C. Gisselbrecht, N. Brousse, F. Reyes, O. Hermine (2006)Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 6
Rushabh Modi, S. Saab (2015)Hepatitis C Virus Infection Is Systemic: Meeting Additional Goals.
The Journal of infectious diseases, 212 3
M. Buettner, S. Toennes, S. Buettner, M. Bickel, R. Allwinn, H. Geiger, H. Bratzke, K. Amann, O. Jung (2014)Nephropathy in illicit drug abusers: a postmortem analysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 63 6
R. Weber, M. Ruppik, M. Rickenbach, A. Spoerri, H. Furrer, M. Battegay, M. Cavassini, A. Calmy, E. Bernasconi, P. Schmid, M. Flepp, J. Kowalska, B. Ledergerber (2013)Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
HIV Medicine, 14
M. Shiffman, Y. Benhamou (2015)Cure of HCV related liver disease
Liver International, 35
L. Adinolfi, L. Restivo, B. Guerrera, A. Sellitto, A. Ciervo, N. Iuliano, L. Rinaldi, A. Santoro, Giovanni Vigni, A. Marrone (2013)Chronic HCV infection is a risk factor of ischemic stroke.
Atherosclerosis, 231 1
Ming-shyan Lin, Su-Er Guo, Mei-Yen Chen, Tung-Jung Huang, Jui-Chu Huang, Jing-Hong Hu, Yu-Sheng Lin (2014)The Impact of Hepatitis C Infection on Ischemic Heart Disease Via Ischemic Electrocardiogram
The American Journal of the Medical Sciences, 347
S. Erqou, A. Mohanty, Pashtoon Kasi, A. Butt (2014)Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection
ISRN Gastroenterology, 2014
L. Elkrief, Pascale Chouinard, N. Bendersky, D. Hajage, B. Larroque, G. Babany, B. Kutala, C. Francoz, N. Boyer, R. Moreau, F. Durand, P. Marcellin, P. Rautou, D. Valla (2014)Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C
L. Adinolfi, R. Zampino, L. Restivo, A. Lonardo, B. Guerrera, A. Marrone, F. Nascimbeni, A. Florio, P. Loria (2014)Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.
World journal of gastroenterology, 20 13
Y. Arase, F. Suzuki, Yoshiyuki Suzuki, N. Akuta, M. Kobayashi, Y. Kawamura, Hiromi Yatsuji, H. Sezaki, T. Hosaka, M. Hirakawa, K. Ikeda, H. Kumada (2009)Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C
Y. Kawaguchi, T. Mizuta (2014)Interaction between hepatitis C virus and metabolic factors.
World journal of gastroenterology, 20 11
G. Farrell (2014)Insulin resistance, obesity, and liver cancer.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 12 1
R. Wiest, Melissa Lawson, M. Geuking (2014)Pathological bacterial translocation in liver cirrhosis.
Journal of hepatology, 60 1
F. Tennant (2015)Hormone abnormalities in patients with severe and chronic pain who fail standard treatments
Postgraduate Medicine, 127
This study is the first, to directly examine lipoprotein subclass concentrations and distributions in HIV/HCV-coinfected participant
J. Dyson, B. Jaques, D. Chattopadyhay, R. Lochan, J. Graham, D. Das, T. Aslam, I. Patanwala, S. Gaggar, M. Cole, K. Sumpter, S. Stewart, J. Rose, M. Hudson, D. Manas, H. Reeves (2014)Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team.
Journal of hepatology, 60 1
J. Peveling-Oberhag, L. Arcaini, M. Hansmann, S. Zeuzem (2013)Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Journal of hepatology, 59 1
J. Brenchley (2006)Microbial translocation is a cause of systemic immune activation in chronic HIV infection
L. Gragnani, E. Fognani, A. Piluso, B. Boldrini, T. Urraro, A. Fabbrizzi, C. Stasi, J. Ranieri, M. Monti, U. Arena, C. Iannacone, G. Laffi, A. Zignego (2015)Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study
J. Womack, C. Chang, K. So-Armah, C. Alcorn, J. Baker, Sheldon Brown, M. Budoff, A. Butt, C. Gibert, M. Goetz, J. Gottdiener, S. Gottlieb, A. Justice, D. Leaf, K. McGinnis, D. Rimland, M. Rodriguez‐Barradas, J. Sico, M. Skanderson, H. Tindle, R. Tracy, A. Warner, M. Freiberg (2014)HIV Infection and Cardiovascular Disease in Women
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 3
R. Wong, F. Kanwal, Z. Younossi, Aijaz Ahmed (2014)Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature
Digestive Diseases and Sciences, 59
J. Casado, A. Marín, A. Moreno, V. Iglesias, M. Pérez-Elías, S. Moreno, Í. Corral (2014)Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients
Journal of NeuroVirology, 20
M. Kraus, A. Schäfer, G. Teuber, H. Porst, K. Sprinzl, S. Wollschläger, C. Keicher, M. Scheurlen (2013)Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C
J. Flemming, J. Yang, E. Vittinghoff, W. Kim, N. Terrault (2014)Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS‐HCC risk model
Alexander Gill, D. Kolson (2014)Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence
Current HIV/AIDS Reports, 11
Y. Hsu, C. Muo, Chun-Yi Liu, W. Tsai, Chih-Cheng Hsu, F. Sung, C. Kao (2014)Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study.
Journal of hepatology, 62 3
PhD Thames, PhD Castellon, MD Singer, R. Nagarajan, PhD Sarma, PharmD Smith, PhD Thaler, J. Truong, BS Schonfeld, PhD Thomas, PhD Hinkin (2015)Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C
Neurology® Neuroimmunology & Neuroinflammation, 2
Yao-Chun Hsu, Jaw-Town Lin, H. Ho, Yu-Hsi Kao, Yen-Tsung Huang, Nai-Wan Hsiao, Ming-Shiang Wu, Yi-Ya Liu, Chun-Ying Wu (2014)Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
Yi-Chun Chen, Hon-Yi Lin, Chung-Yi Li, Moon-Sing Lee, Yu‐Chieh Su (2014)A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease.
Kidney international, 85 5
S. Retamozo, C. Díaz-Lagares, X. Bosch, A. Bové, P. Brito‐Zerón, Maria-Eugenia Gómez, J. Yagüe, X. Forns, M. Cid, M. Ramos-Casals (2013)Life-Threatening Cryoglobulinemic Patients With Hepatitis C
Jordan Cattie, S. Letendre, S. Woods, F. Barakat, W. Perry, M. Cherner, A. Umlauf, D. Franklin, R. Heaton, T. Hassanein, I. Grant, The Group (2014)Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment
Journal of NeuroVirology, 20
He Huang, Rongyan Kang, Zhendong Zhao (2013)Hepatitis C Virus Infection and Risk of Stroke: A Systematic Review and Meta-Analysis
PLoS ONE, 8
T. Giordano, L. Henderson, O. Landgren, E. Chiao, J. Kramer, H. El‐Serag, E. Engels (2007)Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
JAMA, 297 18
J. Lai, D. Shoback, Jacob Zipperstein, B. Lizaola, Samuel Tseng, N. Terrault (2015)Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C
Digestive Diseases and Sciences, 60
L. Sang, B. Chang, Xiao-hang Li, M. Jiang (2013)Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis
BMC Gastroenterology, 13
Y. Kawamura, K. Ikeda, Y. Arase, Hiromi Yatsuji, H. Sezaki, T. Hosaka, N. Akuta, M. Kobayashi, F. Suzuki, Yoshiyuki Suzuki, H. Kumada (2007)Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.
The American journal of medicine, 120 12
J. Pawlotsky (2014)New hepatitis C therapies: the toolbox, strategies, and challenges.
Gastroenterology, 146 5
V. Re, M. Kallan, J. Tate, A. Localio, Joseph Lim, M. Goetz, M. Klein, D. Rimland, M. Rodriguez‐Barradas, A. Butt, C. Gibert, Sheldon Brown, L. Park, R. Dubrow, K. Reddy, J. Kostman, B. Strom, A. Justice (2014)Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C VirusMonoinfected Patients
Annals of Internal Medicine, 160
M. Molnar, Hazem Alhourani, B. Wall, J. Lu, E. Streja, K. Kalantar-Zadeh, C. Kovesdy (2015)Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans
Chantelle Giesbrecht, A. Thornton, Clare Hall-Patch, E. Maan, Hélène Côté, D. Money, M. Murray, N. Pick (2014)Select Neurocognitive Impairment in HIV-Infected Women: Associations with HIV Viral Load, Hepatitis C Virus, and Depression, but Not Leukocyte Telomere Length
PLoS ONE, 9
MD Meer, MD Veldt, PhD Feld, PhD Md, PhD Dufour, PhD Lammert, PhD Duarte-Rojo, MD Heathcote, PhD Manns, PhD Kuske, MD Zeuzem, MD Hofmann, PhD Knegt, P. Md, PhD Janssen (2012)Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
JAMA, 308 24
(2011)EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
Journal of hepatology, 55 2
A. Wheeler, R. Scherzer, Daniel Lee, J. Delaney, P. Bacchetti, M. Shlipak, S. Sidney, C. Grunfeld, P. Tien (2014)HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection
P. Cacoub, V. Ratziu, R. Myers, P. Ghillani, J. Piette, J. Moussalli, T. Poynard (2002)Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.
Journal of hepatology, 36 6
Eric Rosenthal, Patrice Cacoub (2015)Extrahepatic manifestations in chronic hepatitis C virus carriers
N. Pothineni, R. Delongchamp, S. Vallurupalli, Zufeng Ding, Yao Dai, C. Hagedorn, J. Mehta (2014)Impact of Hepatitis C Seropositivity on the Risk of Coronary Heart Disease Events
The American journal of cardiology, 114
Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/03/2020 REVIEW URRENT Extrahepatic comorbidities associated with PINION hepatitis C virus in HIV-infected patients a,b c,d Vicente Soriano and Juan Berenguer Purpose of review HIV infection facilitates progression of hepatitis C virus (HCV)-related liver fibrosis, thus increasing the risk of cirrhosis and decompensated liver disease. Although the primary target of HCV infection is the liver, extrahepatic manifestations related to HCV contribute significantly to morbidity and mortality in patients with chronic hepatitis C. We review current data on extrahepatic comorbidities associated with HCV in HIV-infected patients. Recent findings A large proportion of individuals coinfected with HIV/HCV has extrahepatic manifestations that may be indirectly or directly related to HCV infection. Extrahepatic manifestations include autoimmune and/or lymphoproliferative disorders, and cardiovascular, renal, metabolic, and central nervous system manifestations. Chronic immune activation and systemic inflammation, hallmarks of both HIV and HCV infection, may contribute greatly to extrahepatic comorbidities of HCV in this population group. There is substantial evidence that successful antiviral therapy might reduce both hepatic and extrahepatic manifestations of HCV infection in patients coinfected with HIV/HCV. Summary A substantial burden of the morbidity and the mortality related to HCV in patients with or without HIV infection depends
Current Opinion in HIV & AIDS – Wolters Kluwer Health
Published: Sep 1, 2015
Access the full text.
Sign up today, get DeepDyve free for 14 days.